BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  FDA

  Study: 1/3 of Cancer Accelerated Approval Indications Remain Despite Lack of Confirmation

  A recent study suggests that about one-third of cancer indications with Accelerated Approval pathways are still on product labels without follow-up studies confirming their benefits.

  September 13, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  AzurRx Carves Out Slice of IBD Market in $229 Million Buyout

  AzurRx will change its name to First Wave BioPharma, Inc., and the company’s shares will trade on the Nasdaq under the ticker symbol “FWBI.”

  September 13, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Five Life Sciences Companies Ramping up the Fall Flood of IPOs

  Experts are predicting a record-breaking rush of IPOs this fall as companies flood to the Nasdaq.

  September 13, 2021

   · 

  3 min read

   · 

  Kate Goodwin
• 

  Business

  AbbVie, REGENXBIO Partner on Potential One-Time Treatment for Wet AMD

  The drug, called RGX-314, is a possible one-time treatment for wet AMD, diabetic retinopathy, and other chronic retinal diseases.

  September 13, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  BeiGene’s Immuno-oncology Portfolio Running Strong in Lung Cancer

  BeiGene plans to describe the power of its lung cancer portfolio at the European Society for Medical Oncology Congress 2021. The conference will run from September 16-21.

  September 13, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Inappropriate Sexual Behavior Allegations Confirmed Against Aubrey de Grey

  SENS Research Foundation released findings that confirmed the charges of inappropriate behavior raised by two former female employees against Aubrey de Grey.

  September 13, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Fred Frank, ‘Founding Father’ of Biotech, Dead at 89

  Frederick Frank, an innovator of biotech investment who played a key role in Roche’s acquisition of Genentech and the merger that formed Bristol-Myers Squibb, has died.

  September 13, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  AVITA’s Personalized Vaccine Kit Elicits Robust Immune Memory Response

  The Phase II study showed enhanced immune memory response to the virus in 96% of vaccinated subjects, all of whom were exposed to an environment dominated by the delta variant.

  September 13, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Pharm Country

  Survey Says Immunotherapy May be Effective for Early-Stage Cancer Treatment

  In a recent multinational survey, healthcare providers expressed the belief that immunotherapy will improve outcomes for patients with earlier-stage cancers.

  September 13, 2021

   · 

  4 min read

   · 

  BioSpace Editorial Staff
• 

  Drug Development

  A Recurring COVID-19 Origin Theory and a Vaccine for Kids by Halloween?

  Dr. Scott Gottlieb estimated that a vaccine for the 5-11-year-old age group could be available by Halloween – in a best-case scenario.

  September 13, 2021

   · 

  3 min read

   · 

  Heather McKenzie